- Romosozumab and cardiovascular safety in Japan
-
Takeuchi Y
- KMID: 2520667
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):89-91.
- doi: 10.1016/j.afos.2021.09.002
Romosozumab is a potent pharmacological tool to prevent fractures in osteoporosis patients, and its mechanism of action is distinct from any other drugs. The efficacy of romosozumab to prevent osteoporotic... -
- CITED
-
- Close
- SHARE
-
- Close
- Osteoporosis treatment rates after hip fracture 2011e2019 in Hawaii: Undertreatment of men after hip fractures
-
Taylor L, Kimata C, Siu AM, Andrews SN, Purohit P, Yamauchi M, Bratincsak A, Woo R, Nakasone CK, Lim SY
- KMID: 2520670
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):103-109.
- doi: 10.1016/j.afos.2021.08.002
Objectives: To investigate trends of osteoporosis treatment rates, and factors affecting osteoporosis treatment after hip fracture admission within a single health care system in Hawaii. Methods: A retrospective chart review was... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of osteoporosis in elderly women in Hong Kong
-
Lo SST
- KMID: 2520668
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):92-97.
- doi: 10.1016/j.afos.2021.09.001
Objectives: To determine the prevalence of osteoporosis and the proportion who needed treatment after screening women aged 65 years or older; their treatment acceptance and continuation. Methods: This is an observational... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
-
Mochizuki T, Yano K, Ikari K, Okazaki K
- KMID: 2520672
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):110-114.
- doi: 10.1016/j.afos.2021.08.001
Objectives To investigate effects of romosozumab treatment on disease activity and bone mineral density (BMD) in patients with rheumatoid arthritis (RA) and severe osteoporosis in comparison with effects of denosumab treatment. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
-
Yoshii I, Chijiwa T, Sawada N, Kokei S
- KMID: 2520673
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):115-120.
- doi: 10.1016/j.afos.2021.09.004
Objectives Influence of presenting musculoskeletal ambulation disability symptom complex (MADS) on occurrence of bone fragility fracture (BFF) is investigated with retrospective cohort study. Methods A total of 931 subjects joined in the study.... -
- CITED
-
- Close
- SHARE
-
- Close
- Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model
-
Li-Yu J, Lekamwasam S
- KMID: 2520669
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):98-102.
- doi: 10.1016/j.afos.2021.09.003
Objectives: This study is designed to estimate appropriate intervention thresholds for the Philippines Fracture Risk Assessment Tool (FRAX) model to identify postmenopausal women with high fracture risk. Methods: Age dependent intervention... -
- CITED
-
- Close
- SHARE
-
- Close
- Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
-
Yoshii I, Chijiwa T, Sawada N, Kokei S
- KMID: 2520671
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):115-120.
- doi: 10.1016/j.afos.2021.09.004
Objectives Influence of presenting musculoskeletal ambulation disability symptom complex (MADS) on occurrence of bone fragility fracture (BFF) is investigated with retrospective cohort study. Methods A total of 931 subjects joined in the study.... -
- CITED
-
- Close
- SHARE
-
- Close
